{"doi":"10.1093/cid/ciad405","title":"<i>Mycoplasma genitalium</i> in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions","abstract":"BACKGROUND: Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial Resistance Threats, yet there is no systematic surveillance to monitor change. METHODS: We initiated surveillance in sexual health clinics in 6 cities, selecting a quota sample of urogenital specimens tested for gonorrhea and/or chlamydia. We abstracted patient data from medical records and detected MG and macrolide-resistance mutations (MRMs) by nucleic acid amplification testing. We used Poisson regression to estimate adjusted prevalence ratios (aPRs) and 95% CIs, adjusting for sampling criteria (site, birth sex, symptom status). RESULTS: From October-December 2020 we tested 1743 urogenital specimens: 57.0% from males, 46.1% from non-Hispanic Black persons, and 43.8% from symptomatic patients. MG prevalence was 16.6% (95% CI: 14.9-18.5%; site-specific range: 9.9-23.5%) and higher in St Louis (aPR: 1.9; 1.27-2.85), Greensboro (aPR: 1.8; 1.18-2.79), and Denver (aPR: 1.7; 1.12-2.44) than Seattle. Prevalence was highest in persons <18 years (30.4%) and declined 3% per each additional year of age (aPR: .97; .955-.982). MG was detected in 26.8%, 21.1%, 11.8%, and 15.4% of urethritis, vaginitis, cervicitis, and pelvic inflammatory disease (PID), respectively. It was present in 9% of asymptomatic males and 15.4% of asymptomatic females, and associated with male urethritis (aPR: 1.7; 1.22-2.50) and chlamydia (aPR: 1.7; 1.13-2.53). MRM prevalence was 59.1% (95% CI: 53.1-64.8%; site-specific range: 51.3-70.6%). MRMs were associated with vaginitis (aPR: 1.8; 1.14-2.85), cervicitis (aPR: 3.5; 1.69-7.30), and PID cervicitis (aPR: 1.8; 1.09-3.08). CONCLUSIONS: MG infection is common in persons at high risk of sexually transmitted infections; testing symptomatic patients would facilitate appropriate therapy. Macrolide resistance is high and azithromycin should not be used without resistance testing.","journal":"Clinical Infectious Diseases","year":2023,"id":325828,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":30,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9073,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1044712,"name":"Gina Leipertz","orcid":null,"position":1,"is_corresponding":false},{"id":316703,"name":"Olusegun O. Soge","orcid":"0000-0002-8504-2319","position":2,"is_corresponding":false},{"id":411365,"name":"Stephen J. Jordan","orcid":"0000-0003-4063-2566","position":3,"is_corresponding":false},{"id":301169,"name":"Candice J. McNeil","orcid":"0000-0003-0566-9515","position":4,"is_corresponding":false},{"id":461858,"name":"Preeti Pathela","orcid":"0000-0001-9745-6079","position":5,"is_corresponding":false},{"id":728174,"name":"Hilary Reno","orcid":"0000-0003-4979-5492","position":6,"is_corresponding":false},{"id":723791,"name":"Karen A. Wendel","orcid":null,"position":7,"is_corresponding":false},{"id":1044713,"name":"Anika Parker","orcid":null,"position":8,"is_corresponding":false},{"id":301165,"name":"William M. Geisler","orcid":"0000-0002-0603-2404","position":9,"is_corresponding":false},{"id":483089,"name":"Damon Getman","orcid":"0000-0003-3530-2837","position":10,"is_corresponding":false},{"id":311289,"name":"Matthew R. Golden","orcid":"0000-0001-7449-3774","position":11,"is_corresponding":false},{"id":1044714,"name":"for the MyGeniUS Study Team","orcid":null,"position":12,"is_corresponding":false},{"id":932351,"name":"Anna Berzkalns","orcid":null,"position":13,"is_corresponding":false},{"id":1044715,"name":"Alfred Iqbal","orcid":null,"position":14,"is_corresponding":false},{"id":1044716,"name":"Rushlenne Pascual","orcid":null,"position":15,"is_corresponding":false},{"id":1044717,"name":"Erika Wakatake","orcid":null,"position":16,"is_corresponding":false},{"id":1044718,"name":"Paul D. Swenson","orcid":null,"position":17,"is_corresponding":false},{"id":1041262,"name":"Lora Fortenberry","orcid":null,"position":18,"is_corresponding":false},{"id":1044719,"name":"Lisa Coss","orcid":null,"position":19,"is_corresponding":false},{"id":1016367,"name":"Kevin Kamis","orcid":"0000-0003-0301-5219","position":20,"is_corresponding":false},{"id":783355,"name":"Masayo Nishiyama","orcid":null,"position":21,"is_corresponding":false},{"id":1044720,"name":"Lucy Alderton","orcid":null,"position":22,"is_corresponding":false},{"id":1044721,"name":"Lawrence Weingarten","orcid":null,"position":23,"is_corresponding":false},{"id":458570,"name":"Laura J. Blair","orcid":"0000-0002-4981-5564","position":24,"is_corresponding":false},{"id":1044722,"name":"Dana Strope","orcid":null,"position":25,"is_corresponding":false},{"id":777196,"name":"Andrea Lewis","orcid":"0000-0002-9501-4899","position":26,"is_corresponding":false},{"id":976239,"name":"Kelly Jamison","orcid":null,"position":27,"is_corresponding":false},{"id":301166,"name":"Lisa E. Manhart","orcid":"0000-0002-4896-7654","position":0,"is_corresponding":true}],"reference_count":43,"raw_metadata":null,"created_at":"2026-07-19T01:08:28.266998Z","pmid":"37402645","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}